Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/2012
04/26/2012WO2012031237A8 Fused tricyclic ether carbamates and their use
04/26/2012WO2012030050A3 Pharmaceutical composition for the prevention or treatment of degenerative neurological brain disorders
04/26/2012WO2012029076A3 Stable pharmaceutical composition
04/26/2012WO2012029015A3 Anticaries dentifrice composition that includes anticaries propolis as an active principle
04/26/2012WO2012027811A3 Anesthetic association, anesthetic composition, and anesthetic medicament for veterinary use
04/26/2012WO2012027794A3 Method of treatment and agents useful for same
04/26/2012WO2012024670A3 Composition and methods for treating glioblastoma
04/26/2012WO2012024669A4 Method of drug detoxification
04/26/2012WO2012024605A3 Devices and methods for intravaginal delivery of drugs and other substances
04/26/2012WO2012024405A3 Curcumin compositions and uses thereof
04/26/2012WO2012024282A3 1,5-diphenyl-penta-1,4-dien-3-one compounds
04/26/2012WO2012024255A3 Camkk-beta as a target for treating cancer
04/26/2012WO2012021778A3 Methods for blocking cell proliferation and treating diseases and conditions responsive to cell growth inhibition
04/26/2012WO2012021165A9 Methods and compositions for treating disorders associated with hyperactive immune system
04/26/2012WO2012020301A3 Oral controlled release pharmaceutical compositions of blonanserin
04/26/2012WO2012018742A3 Dextromethorphan antitussive compositions
04/26/2012WO2012017326A3 Apparatus and process for encapsulating capsules or other solid dosage forms within capsules
04/26/2012WO2012016266A3 Tetrahydro-anthracenone derivative
04/26/2012WO2012016133A3 Ros1 kinase inhibitors for the treatment of glioblastoma and other p53-deficient cancers
04/26/2012WO2012015789A3 Composition and method for the topicaltreatment of dermatitis
04/26/2012WO2012015255A3 Novel montelukast 4-halobenzylamine salt and method for preparing montelukast sodium salt by using the same
04/26/2012WO2012012304A3 Method of treating refractory cancer
04/26/2012WO2012009347A3 Treatment of bcl2 binding component 3 (bbc3) related diseases by inhibition of natural antisense transcript to bbc3
04/26/2012WO2012006550A3 Methods and compositions for treatment of lipogenic virus related conditions
04/26/2012WO2012006181A3 Compositions and methods for inhibiting oncogenic micrornas and treatment of cancer
04/26/2012WO2012006117A3 Reduction of microglia-mediated neurotoxicity by kca3.1 inhibition
04/26/2012WO2012002773A3 Phenylcarbamate compound and muscle relaxant containing the same
04/26/2012WO2012002688A3 Methods of treating restless legs syndrome
04/26/2012WO2012002687A3 Methods for treating bipolar disorder
04/26/2012WO2012002680A3 2-pyridyl substituted imidazoles as therapeutic alk5 and/or alk4 inhibitors
04/26/2012WO2011160093A3 Methods and systems for modulating hormones and related methods, agents and compositions
04/26/2012WO2011159129A3 Novel rhodanine derivatives, method for preparing same, and pharmaceutical composition for the prevention or treatment of aids containing the rhodanine derivatives as active ingredients
04/26/2012WO2011156786A3 6-(ethynyl)pyrido[2,3-d]pyrimidin-7(8h)-ones for the treatment of cns disorders
04/26/2012WO2011156640A3 8-(HETEROARYLMETHYL)PYRIDO[2,3-d]PYRIMIDIN-7(8H)-ONES FOR THE TREATMENT OF CNS DISORDERS
04/26/2012WO2011156337A3 Macrocyclic hepatitis c serine protease inhibitors
04/26/2012WO2011156242A3 Improved anti-lysophospholipid antibody design using antibody structures
04/26/2012WO2011155793A3 Pharmaceutical composition comprising amide derivative or pharmaceutically acceptable salt thereof
04/26/2012WO2011153513A3 Nanoemulsion composition containing vitamin k
04/26/2012WO2011152658A3 Pharmaceutical composition comprising piperazine dithioctate and glimepiride
04/26/2012WO2011152657A3 Acetyl-l-carnitine malate, process for preparing the same, and pharmaceutical composition comprising the same
04/26/2012WO2011150395A3 Nutrient compositions
04/26/2012WO2011141783A3 Pharmaceutical composition comprising irbesartan
04/26/2012WO2011135582A3 Pharmaceutical compositions of dronedarone
04/26/2012WO2011110939A3 Pharmaceutical compositions of substituted benzhydrylpiperazines
04/26/2012WO2011107922A3 Extended release composition of milnacipran
04/26/2012WO2011103552A9 Amp derivatives for treating cardiac diseases
04/26/2012WO2011101867A3 Substantially pure salts of febuxostat and processes for preparation thereof
04/26/2012WO2011061554A8 Pharmaceutical composition for the treatment of bladder disorders
04/26/2012WO2011058474A8 N1-pyrazolospiroketone acetyl-coa carboxylase inhibitors
04/26/2012WO2011051354A4 Transdermal pharmaceutical compositions comprising active agents
04/26/2012WO2011047466A8 Process and compounds for the manufacture of oseltamivir and analogs thereof, and new antiviral agents
04/26/2012WO2011031926A8 Compositions of n-benzyl-3-(4-chlorophenyl)-2-[methyl-[2-oxo-2-(3,4,5-trimethoxyphenyl) acetyl]amino]-n-[3-(4-pyri(dyl)-1-[2-[4-pyridyl)ethyl]propyl]propanamide and uses thereof
04/26/2012WO2011026024A3 Imidazo [4,5-d] pyridazine compounds for treating viral infections
04/26/2012WO2011012217A3 Co-precipitate comprising a phosphodiesterase-5 inhibitor (pde-5-inhibitor) and a pharmaceutically compatible carrier, production and use thereof
04/26/2012WO2009156861A8 Substituted pyrimidone derivatives
04/26/2012WO2009118657A8 Polymorphic form of an aminoindan mesylate derivative
04/26/2012US20120101427 Novel photosensitizer formulations for oral administration
04/26/2012US20120101169 Methods of providing anticoagulation effects in subjects
04/26/2012US20120101168 Deuterium enriched rasagiline
04/26/2012US20120101167 Treatment of ocular and cerebral ischemia
04/26/2012US20120101166 Composition and method for irrigation of a prepared dental root canal
04/26/2012US20120101163 Composition for inhibiting cancer metastasis
04/26/2012US20120101162 Methods and compositions for inducing physiological hypertrophy
04/26/2012US20120101161 Fatty acid analogues for the treatment of inflammatory and autoimmune disorders
04/26/2012US20120101160 Use of chemical chaperones to treat glaucoma caused by misfolded or misprocessed proteins
04/26/2012US20120101159 Ibuprofen lysinate oral suspension
04/26/2012US20120101158 Surface Anesthetic Agent
04/26/2012US20120101157 4,5-Diamino-3-Halo-2-Hydroxybenzoic Acid Derivatives and Preparations Thereof
04/26/2012US20120101156 COMPOSITIONS COMPRISING A RETINOID AND AN NFkB-INHIBITOR AND THEIR METHODS OF USE
04/26/2012US20120101155 Zinc Salt Compositions for the Prevention of Dermal and Mucosal Irritation
04/26/2012US20120101154 Compositions and methods for increasing compliance with therapies using aldehyde dehydrogenase inhibitors and treating alcoholism
04/26/2012US20120101153 Rocaglaol derivatives as cardioprotectant agents and as antineoplastic agents
04/26/2012US20120101152 Neurite elongation agent, memory-improving agent and anti-alzheimer agent comprising 4'-demethylnobiletin or 4'-demethyltangeretin as active ingredient, and process for production of the compound
04/26/2012US20120101151 Combination therapy and uses thereof for treatment and prevention of parasitic infection and disease
04/26/2012US20120101150 Use of vgii3 activity modulator for the modulation of adipogenesis
04/26/2012US20120101149 Betulinic Acid Derivatives and Methods of Use Thereof
04/26/2012US20120101148 lipid formulation
04/26/2012US20120101147 Inhibition of hdac2 to promote memory
04/26/2012US20120101146 Pharmaceutical composition comprising rotigotine salts (acid or na), especially for iontophoresis
04/26/2012US20120101145 Oligomer-Containing Pyrrolidine Compounds
04/26/2012US20120101144 Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof
04/26/2012US20120101143 Compounds Having Activity in Increasing Ion Transport by Mutant-CFTR and Uses Thereof
04/26/2012US20120101142 Ready to Use Ketorolac Formulations
04/26/2012US20120101141 Gel compositions and methods of use
04/26/2012US20120101140 Econazole Composition and Methods of Treatment Therewith
04/26/2012US20120101139 Econazole Composition and Methods of Treatment Therewith
04/26/2012US20120101138 Fluorinated aminotriazole derivatives
04/26/2012US20120101137 Novel thiophenecarboxamide derivative and pharmaceutical use thereof
04/26/2012US20120101136 5-membered heteroaryl derivatives used as sphingosine 1- phosphate receptor agonists
04/26/2012US20120101134 5-membered heteroaryl derivatives used as sphingosine 1-phosphate receptor agonists
04/26/2012US20120101132 New Substituted Oxindole Derivative
04/26/2012US20120101131 Aminotetrahydroindazoloacetic Acids
04/26/2012US20120101130 Methods for delivering a drug to a hospital patient for short-term use while minimizing long-term use of the drug
04/26/2012US20120101129 Methylphenidate Derivatives and Uses of Them
04/26/2012US20120101128 Perhexiline for treating chronic heart failure
04/26/2012US20120101127 Novel tetrahydroquinoline derivatives
04/26/2012US20120101126 Crystalline forms of pitavastatin calcium
04/26/2012US20120101125 Substituted isoquinoline derivatives, pharmaceutical compositions, and methods of use as beta-secretase inhibitors
04/26/2012US20120101124 1,2,4-oxadiazol derivatives, their pharmaceutical compositions and their use as sphingosine 1-phosphate 1 receptor agonists
04/26/2012US20120101123 Compounds
1 ... 1256 1257 1258 1259 1260 1261 1262 1263 1264 1265 1266 1267 1268 1269 1270 1271 1272 1273 1274 1275 1276 ... 7860